Ontology highlight
ABSTRACT: Purpose
Resection of liver-only colorectal liver metastases (CRLM) with perioperative chemotherapy is potentially curative. Specific primary tumor and liver metastasis characteristics have been validated to estimate the risk of recurrence. We hypothesize that the time interval from diagnosis of CRLM to surgery, or time to surgery (TTS), is clinically prognostic.Methods
Patients from a prospectively maintained institutional database at a Comprehensive Cancer Center from May 2003 to January 2018 were reviewed. Clinicopathologic, perioperative treatment, and TTS data were collected. TTS was categorized into short (?6 months) intervals.Results
Two hundred eighty-one patients were identified. While overall survival (OS) was similar across TTS, postoperative overall survival (postoperative OS) of long TTS was associated with worse survival, 44 months (95% CI, 34-52) compared to short TTS, 59 months (95% CI, 43-79), and intermediate TTS, 63 months (95% CI, 52-108), both p?ConclusionShort and intermediate TTS had similar survival although patients with intermediate TTS may have better odds of long-term OS. While long TTS was associated with worse survival, likely due to higher disease burden, long-term survivors were still observed.
SUBMITTER: Chen EY
PROVIDER: S-EPMC7900034 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
Chen Emerson Y EY Mayo Skye C SC Sutton Thomas T Kearney Matthew R MR Kardosh Adel A Vaccaro Gina M GM Billingsley Kevin G KG Lopez Charles D CD
Journal of gastrointestinal cancer 20210301 1
<h4>Purpose</h4>Resection of liver-only colorectal liver metastases (CRLM) with perioperative chemotherapy is potentially curative. Specific primary tumor and liver metastasis characteristics have been validated to estimate the risk of recurrence. We hypothesize that the time interval from diagnosis of CRLM to surgery, or time to surgery (TTS), is clinically prognostic.<h4>Methods</h4>Patients from a prospectively maintained institutional database at a Comprehensive Cancer Center from May 2003 t ...[more]